In an adult with cirrhosis who undergoes large‑volume paracentesis (>5 L of ascites removed), how long should albumin be administered?

Albumin Administration After Large-Volume Paracentesis >5L

Albumin should be administered as a single infusion at the time of large-volume paracentesis (>5L), not as a prolonged course of therapy. The standard approach is to give 20-25% intravenous albumin at a dose of 6-8 grams per liter of ascites removed, administered during or immediately after the procedure 1, 2.

Timing and Duration

The evidence is clear that albumin is given as a one-time infusion, not as ongoing therapy:

• Administration occurs at the time of paracentesis - either during the procedure or immediately after completion 2
• There is no recommendation for continued albumin infusions beyond the initial post-paracentesis dose in standard cases
• The goal is to prevent post-paracentesis circulatory dysfunction (PICD), which develops acutely after fluid removal, not to provide ongoing volume support

Dosing Strategy

The most recent AGA guidelines 1 recommend:

• 6-8 grams of 20-25% albumin per liter of ascites removed when >5L is drained
• For a typical 10L paracentesis, this translates to 60-80 grams total (approximately 240-320 mL of 25% albumin)
• This can be given as a single infusion or divided during the procedure

Special Populations Requiring Modified Approach

Patients with acute-on-chronic liver failure (ACLF) represent an important exception 2:

• These patients should receive albumin at 6-8 g/L regardless of volume removed (even <5L)
• Still administered as a single dose at time of paracentesis

High-risk patients may warrant albumin even with smaller volume paracentesis 1:

• Hypotension at baseline
• Pre-existing renal insufficiency (creatinine >1.0 mg/dL)
• Electrolyte abnormalities
• Consider more liberal dosing (potentially higher end of 6-8 g/L range)

Evidence Supporting Single-Dose Approach

The landmark studies establishing albumin use 3 demonstrated that:

• A single albumin infusion (40g after each tap in the original study) prevented the marked elevation in plasma renin activity and aldosterone that occurred without albumin
• Renal impairment developed in 21% without albumin vs. 0% with albumin when given as a single dose
• No studies support or recommend continued daily albumin infusions after paracentesis

More recent data 4 confirms that even lower doses than traditionally used (6.5 g/L vs. 8.3 g/L) are effective when given as a single infusion, with no difference in rates of hyponatremia, renal impairment, or hypotension.

Critical Pitfalls to Avoid

Volume overload is an increasingly recognized complication 5, 6:

• Occurs in approximately 20% of patients receiving albumin
• More common in women (40% vs. 16% in men)
• Associated with higher rates of variceal bleeding
• Monitor for signs of fluid overload, especially in patients with:
  • Baseline cardiac dysfunction
  • Small body habitus
  • Multiple recent albumin infusions

Do not confuse with other albumin indications that require different dosing schedules:

• Spontaneous bacterial peritonitis: 1.5 g/kg day 1, then 1 g/kg day 3 2
• Hepatorenal syndrome/AKI: Daily dosing for 24-48 hours 7
• These are separate clinical scenarios with distinct protocols

Practical Implementation

For a patient undergoing large-volume paracentesis >5L:

1. Calculate total albumin dose: (Liters removed) × (6-8 grams)
2. Administer as single infusion: Give during or immediately after paracentesis completion
3. Monitor for complications: Check blood pressure, watch for dyspnea suggesting volume overload
4. No routine follow-up doses: Unless patient develops separate indication (SBP, AKI)

The FDA labeling 8 supports this approach, noting that albumin "may be required to support blood volume" after ascitic fluid removal in cirrhosis, without specifying prolonged administration.

Bottom line: Albumin after large-volume paracentesis is a single-dose intervention timed to the procedure itself, not an ongoing therapy requiring days of administration.